66 related articles for article (PubMed ID: 26185030)
21. [Genetic changes in colorectal cancer].
Hibi K; Nakao A
Nihon Rinsho; 2003 Sep; 61 Suppl 7():77-80. PubMed ID: 14574859
[No Abstract] [Full Text] [Related]
22. Erasure of MLH1 methylation in spermatozoa-implications for epigenetic inheritance.
Hitchins MP; Ward RL
Nat Genet; 2007 Nov; 39(11):1289. PubMed ID: 17968340
[No Abstract] [Full Text] [Related]
23. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
24. Segregation of a novel MLH1 mutation in an Iranian Lynch syndrome family.
Ghafouri-Fard S; Fardaei M; Lankarani KB; Miryounesi M
Gene; 2015 Oct; 570(2):304-5. PubMed ID: 26149658
[TBL] [Abstract][Full Text] [Related]
25. Cell-free assay breakthrough for MLH1 variants.
Hofstra RM; Sijmons RH
Hum Mutat; 2010 Mar; 31(3):v. PubMed ID: 20162719
[No Abstract] [Full Text] [Related]
26. Molecular genetic alterations in radiation-induced astrocytomas.
Brat DJ; James CD; Jedlicka AE; Connolly DC; Chang E; Castellani RJ; Schmid M; Schiller M; Carson DA; Burger PC
Am J Pathol; 1999 May; 154(5):1431-8. PubMed ID: 10329596
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
[TBL] [Abstract][Full Text] [Related]
28. Rectal carcinoma after radiotherapy for cervical carcinoma in patients with a family history of colorectal carcinoma: report of two cases.
Melichar B; Ryska A; Krepelová A; Holecková P
Eur J Gynaecol Oncol; 2007; 28(4):319-21. PubMed ID: 17713103
[TBL] [Abstract][Full Text] [Related]
29. [Gene diagnosis of gastric cancer].
Yasui W; Oue N; Kuniyasu H
Nihon Rinsho; 2001 Apr; 59 Suppl 4():213-8. PubMed ID: 11424380
[No Abstract] [Full Text] [Related]
30. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.
Kastrinos F; Stoffel EM; Balmaña J; Steyerberg EW; Mercado R; Syngal S
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2044-51. PubMed ID: 18708397
[TBL] [Abstract][Full Text] [Related]
31. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
Gravendeel LA; Kloosterhof NK; Bralten LB; van Marion R; Dubbink HJ; Dinjens W; Bleeker FE; Hoogenraad CC; Michiels E; Kros JM; van den Bent M; Smitt PA; French PJ
Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503
[TBL] [Abstract][Full Text] [Related]
32. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
33. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
[TBL] [Abstract][Full Text] [Related]
34. Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma.
Schittenhelm J; Mittelbronn M; Meyermann R; Melms A; Tatagiba M; Capper D
Acta Neuropathol; 2011 Nov; 122(5):651-2. PubMed ID: 21983902
[No Abstract] [Full Text] [Related]
35. Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene.
Tang R; Hsiung C; Wang JY; Lai CH; Chien HT; Chiu LL; Liu CT; Chen HH; Wang HM; Chen SX; Hsieh LL;
Clin Genet; 2009 Apr; 75(4):334-45. PubMed ID: 19419416
[TBL] [Abstract][Full Text] [Related]
36. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
[TBL] [Abstract][Full Text] [Related]
37. Expression analysis of MLH3, MLH1, and MSH4 in maturation arrest.
Ferrás C; Fernandes S; Silva J; Barros A; Sousa M
Reprod Sci; 2012 Jun; 19(6):587-96. PubMed ID: 22344730
[TBL] [Abstract][Full Text] [Related]
38. Genomic discoveries in adult astrocytoma.
Wang J; Bettegowda C
Curr Opin Genet Dev; 2015 Feb; 30():17-24. PubMed ID: 25616158
[TBL] [Abstract][Full Text] [Related]
39. Towards a genomic definition of completeness of resection?
Vogelbaum MA
Neuro Oncol; 2014 Jan; 16(1):2-3. PubMed ID: 24366973
[No Abstract] [Full Text] [Related]
40. Ethical issues in cancer genetics: I 1) whose information is it?
Schneider KA; Chittenden AB; Branda KJ; Keenan MA; Joffe S; Patenaude AF; Reynolds H; Dent K; Eubanks S; Goldman J; Leroy B; Warren NS; Taylor K; Vockley CW; Garber JE
J Genet Couns; 2006 Dec; 15(6):491-503. PubMed ID: 17106632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]